13F-HR filed by FourWorld Capital Management LLC
FourWorld Capital Management LLC filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-14, with 22 holding rows worth $148,536,493.
- Accession
- 0001770525-25-000008
- Filer
- CIK 1770525
- Filed
- 2025-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2025
A holdings report, 22 entries on the cover page, a total value of $148,536,493 stated on the cover page (in dollars after the unit check, H1), rows summing to $148,536,493 with VALUE read as dollars as filed, 13F file number 028-22163. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ENSTAR GROUP LIMITED | G3075P101 | SHS | 208,600 | $70,164,696 | dollars as filed | |
| GOLDEN OCEAN GROUP LTD | G39637205 | SHS NEW | 2,501,000 | $18,307,320 | dollars as filed | |
| SKECHERS U S A INC | 830566105 | CL A | 240,000 | $15,144,000 | dollars as filed | |
| EVOLV TECHNOLOGIES HLDNGS IN | 30049H102 | COM CL A | 1,606,563 | $10,024,953 | dollars as filed | |
| SPY | 78462F103 | SHS | 15,000 | $9,267,750 | dollars as filed | put |
| Bristol-Myers Squibb Company | 110122108 | COM | 100,000 | $4,629,000 | dollars as filed | |
| Arbutus Biopharma Corp | 03879J100 | Common Shares, without par value | 1,226,710 | $3,790,534 | dollars as filed | |
| SERITAGE GROWTH PPTYS | 81752R100 | CL A | 1,113,243 | $3,428,788 | dollars as filed | |
| ZEEKR INTELLIGENT TECHNOLOGY | 98923K103 | SPON ADS | 86,400 | $2,203,200 | dollars as filed | |
| AIRSCULPT TECHNOLOGIES INC | 009496100 | COMMON STOCK | 382,886 | $1,849,339 | dollars as filed | |
| NEURONETICS INC | 64131A105 | COM | 500,000 | $1,745,000 | dollars as filed | |
| TASKUS INC | 87652V109 | CLASS A COM | 100,000 | $1,676,000 | dollars as filed | |
| EXAGEN INC | 30068X103 | COM | 208,527 | $1,455,518 | dollars as filed | |
| SOLID POWER INC CLASS A COM | 83422N105 | Stock | 477,129 | $1,044,913 | dollars as filed | |
| KASPI KZ JSC | 48581R205 | SPONSORED ADS | 10,000 | $848,900 | dollars as filed | |
| STARLING ONCOLOGY INC | 68236X100 | COMMON STOCK | 391,650 | $802,883 | dollars as filed | |
| ENERGY SVCS ACQUISITION CORP | 29271Q103 | COM | 80,554 | $800,707 | dollars as filed | |
| CVRX INC | 126638105 | COMMON STOCK | 124,123 | $729,843 | dollars as filed | |
| INOTIV INC | 45783Q100 | COM | 141,377 | $257,306 | dollars as filed | |
| CHEMOURS CO COM | 163851108 | Stock | 13,600 | $155,720 | dollars as filed | |
| INSEEGO CORP | 45782B302 | COMMON STOCK | 13,200 | $108,768 | dollars as filed | |
| TEVOGEN BIO HLDGS INC | 88165K119 | *W EXP 02/14/202 | 1,450,000 | $101,355 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001770525-25-000008 | this filing | 2025-08-14 | acceptance time not in the bulk data set |